Mycronic AB (publ)
MICLF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $181 | $2,066 | $2,142 | $2,059 |
| % Growth | -91.2% | -3.5% | 4% | – |
| Cost of Goods Sold | $97 | $963 | $832 | $1,055 |
| Gross Profit | $84 | $1,103 | $1,310 | $1,004 |
| % Margin | 46.3% | 53.4% | 61.2% | 48.8% |
| R&D Expenses | $24 | $242 | $222 | $216 |
| G&A Expenses | $0 | $114 | $106 | $102 |
| SG&A Expenses | $24 | $286 | $281 | $274 |
| Sales & Mktg Exp. | $0 | $172 | $175 | $172 |
| Other Operating Expenses | $0 | $0 | $0 | -$12 |
| Operating Expenses | $48 | $528 | $503 | $478 |
| Operating Income | $36 | $575 | $807 | $526 |
| % Margin | 20% | 27.8% | 37.7% | 25.5% |
| Other Income/Exp. Net | -$9 | -$1 | -$21 | $17 |
| Pre-Tax Income | $27 | $574 | $786 | $543 |
| Tax Expense | $4 | $128 | $165 | $78 |
| Net Income | $23 | $446 | $620 | $460 |
| % Margin | 12.7% | 21.6% | 28.9% | 22.3% |
| EPS | 0.12 | 2.28 | 3.18 | 2.36 |
| % Growth | -94.7% | -28.3% | 34.7% | – |
| EPS Diluted | 0.12 | 2.28 | 3.18 | 2.36 |
| Weighted Avg Shares Out | 195 | 196 | 98 | 98 |
| Weighted Avg Shares Out Dil | 195 | 196 | 98 | 98 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $6 | $10 | $16 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $9 | $0 | $0 | $10 |
| EBITDA | $37 | $575 | $807 | $536 |
| % Margin | 20.2% | 27.8% | 37.7% | 26% |